Liver cirrhosis: vizsgálatok itt: Japán
6 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Bunkyō-Ku, Fukui-shi, Kyoto, Maebashi, Minato-Ku, Musashino, Nagasaki, Ōgaki, Saga, Sakai, Shinjuku, Suita-shi, Tsu, Wakayama, Yokohama
- Életkor
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - 3. fázisTaking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Bunkyō City, Chiba, Ehime, Toon, Fukui-shi, Fukuoka, Fukuoka, Fukuoka, Kurume, Gifu, Gifu, Gifu, Ogaki, Hanishina-gun, Hiroshima, Hokkaido, Sapporo, Ibaraki, Inashiki-gun, Isehara-Shi, Ishikawa, Kanazawa, Izumo, Kagoshima, Kanagawa, Kawasaki, Kita-gun, Kobe, Kumamoto, Kure, Kyoto, Miyazaki, Musashino, Nagano, Matsumoto, Nagasaki, Omura, Nara, Kashihara, Narita, Niigata, Nishinomiya, Ōita, Okayama, Osaka, Saga, Sakai, Sapporo, Sendai, Shiwa-gun, Shizuoka, Hamamatsu, Shizuoka, Izunokuni, Suita-shi, Suita-Shi, Takasaki-shi, Tokyo, Tokyo, Bunkyo-ku, Tokyo, Minato-ku, Toyoake-shi, Tsu, Wakayama, Yokohama
- Életkor
- 18 év and over
- People
- 1590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - 3. fázisTaking peopleA Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Where
- Kawasaki-shi, Ōgaki
- Életkor
- 18 év to 75 év
- People
- 1740 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07701993 - 3. fázisTaking peopleA Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Where
- Kawasaki-shi, Ōgaki
- Életkor
- 18 év to 75 év
- People
- 380 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07704892 - 2. fázisTaking peopleA Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
- Where
- Bunkyo Ku, Osaka, Sapporo, Sendai
- Életkor
- 18 év to 79 év
- People
- 7
- Run by
- Kiminori Kimura, MD
See details and how to joinNCT07681089 - No phaseTaking peopleLiver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Where
- Fukuoka, Hiroshima, Kyoto, Nagasaki, Tokyo
- Életkor
- 18 év to 80 év
- People
- 3000 worldwide
- Run by
- European Foundation for Study of Chronic Liver Failure
See details and how to joinNCT04613921